Zinc for Colds: Why Most Lozenges on the Shelf Are the Wrong Dose

Why Europe keeps buying it every winter

Zinc's cold-fighting reputation is older than vitamin C's modern one and rests on a real biological mechanism, not folklore: zinc ions can interfere with rhinovirus replication and with the intercellular adhesion molecule the virus uses to enter nasal cells. That gave the claim a plausibility vitamin C never quite had, and pharmacy chains across the EU and UK built a genuine product category around it — lozenges, sprays, syrups, and daily tablets marketed as "immune support", sold alongside vitamin C every autumn.

The global market for zinc cold lozenges alone is now worth over a billion euros a year and growing at roughly 7% annually, with Europe as its second-largest region after North America. Pharmacies and drugstores handle the largest share of that — consumers trust the channel, and a pharmacist recommending zinc carries more weight than an influencer doing the same.

What most of that market doesn't advertise is that "zinc" isn't one product. It's a mineral sold in at least four different chemical salts, three delivery routes, and doses that vary more than tenfold between brands — and the clinical trial record shows that these differences are not cosmetic. They're the difference between a real effect and a placebo.

What the science actually says

• Prevention doesn't work. Across 15 prevention trials in the 2024 Cochrane review, daily zinc supplementation for five to eighteen months barely changed the risk of catching a cold (RR 0.93) and did not shorten colds that occurred anyway — both rated low- to moderate-certainty evidence.
• Treatment has a real but conditional effect. In the same review's 19 treatment trials, zinc taken after symptoms started reduced cold duration by about 2.4 days on average — but Cochrane rated the certainty low, citing wide variation between studies and incomplete reporting.
• Dose is the variable nobody puts on the front of the label. A separate line of research going back to a 2011 systematic review found a near-binary split: five trials using under 75mg of elemental zinc per day uniformly found no benefit; trials above that threshold, specifically using zinc acetate, found colds cut by roughly a third — about 2.7 to 2.9 fewer days. Most consumer "immune support" zinc tablets sold at 10-25mg a day are nowhere near that range.
• The salt matters as much as the dose. Zinc acetate consistently outperformed zinc gluconate in head-to-head meta-analyses (roughly 40% vs. 28% shorter colds). The reason is chemical, not marketing: some gluconate lozenges are flavoured with citric acid, which binds free zinc ions in saliva so tightly that little or no active zinc reaches the throat tissue — a formulation flaw, not a dosing one.
• Cochrane's own numbers are being disputed. A published critique of the 2024 review argues its headline figure understates the effect by using an absolute day-count instead of a relative one (on a relative scale, the critics calculate a 37% reduction in adult cold duration) and by pooling incompatible interventions — one trial dosed at 190mg/day of lozenge zinc was averaged together with a nasal spray trial dosed at 0.046mg/day, a difference of more than 4,000-fold.
• The nasal route is a separate story, and a cautionary one. Intranasal zinc products were pulled from the market after regulators linked them to zinc-induced anosmia — permanent or long-lasting loss of smell, reported in over a hundred cases. It's a reminder that "zinc" spans genuinely different risk profiles depending on how it's delivered, which is also why pooling nasal and oral trials together, as Cochrane's critics point out, is questionable science.

What the label claims vs. what the evidence shows

Our Conclusion

Zinc for colds is a rarer case in supplement science: the effect is real, mechanistically plausible, and shows up consistently in the trials that used the right form and dose — which makes it more defensible than most of what shares a shelf with it. But "zinc works" is doing a lot of unearned work on packaging that doesn't specify salt, dose, or timing. If you're buying it to prevent colds, the evidence says don't bother. If you're buying it to shorten one that's already started, look past the front label for elemental zinc content and salt form — zinc acetate, upwards of 75mg a day, started within 24 hours of symptoms — because the trials that found nothing were usually testing a lozenge that was never going to work at the dose it was sold at.